Orion Nelson
Family · Keller, TXNPI 1508401670
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 202 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 38 manufacturers, the largest accounting for just 12.5% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2023 at $1,480 and has fallen 98.6% since, to $20 in 2024.
Across 202 payments — averaging $16.32 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Boehringer Ingelheim$411
- Novo Nordisk$328
- Pfizer$306
- GSK$295
- AbbVie$278
- Lilly USA, LLC$210
- plus $1K from 32 others
What the payments were for
- Food & beverage$3,296100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Boehringer Ingelheim | 24 | $411 |
| Novo Nordisk | 23 | $328 |
| Pfizer | 23 | $306 |
| GSK | 15 | $295 |
| AbbVie | 18 | $278 |
| Lilly USA, LLC | 14 | $210 |
| Bayer | 9 | $146 |
| AstraZeneca(2 entities) | 6 | $113 |
| Antares Pharma, Inc. | 6 | $105 |
| Takeda Pharmaceuticals U.S.A., Inc. | 6 | $103 |
| Johnson & Johnson | 6 | $93 |
| Supernus Pharmaceuticals, Inc. | 4 | $83 |
| Astellas Pharma US Inc | 5 | $81 |
| Kowa Pharmaceuticals America, Inc. | 4 | $60 |
| Biohaven Pharmaceutical Holding Company Ltd. | 3 | $53 |
| Idorsia Pharmaceuticals US Inc | 3 | $51 |
| Novartis | 2 | $50 |
| Sanofi | 2 | $50 |
| Alnylam Pharmaceuticals Inc. | 2 | $46 |
| Bausch Health US, LLC | 3 | $46 |
| Genentech USA, Inc. | 4 | $37 |
| Exact Sciences | 2 | $31 |
| Scilex Pharmaceuticals Inc. | 2 | $27 |
| Jazz Pharmaceuticals Inc. | 2 | $25 |
| Teva Pharmaceuticals USA, Inc. | 1 | $24 |
| Dexcom, Inc. | 1 | $22 |
| Renalytix AI, Inc. | 1 | $22 |
| Amarin Pharma, Inc. | 1 | $21 |
| Sanofi Pasteur Inc. | 1 | $21 |
| Halozyme Inc | 1 | $20 |
| Medtronic | 1 | $19 |
| Aurinia Pharma U.S., Inc. | 1 | $19 |
| Mannkind Corporation | 1 | $19 |
| Phadia US Inc. | 1 | $17 |
| Biohaven Pharmaceuticals, Inc. | 1 | $16 |
| Eisai Inc. | 1 | $16 |
| Amgen | 1 | $16 |
| Inspire Medical Systems, Inc. | 1 | $14 |
How this compares
$3,296 in reported general payments places this provider in the 85th percentile of 15,456 family providers in Texas.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Omeprazole | 19 | $370 |
| Levothyroxine Sodium | 25 | $295 |
| Amlodipine Besylate | 14 | $108 |
| Atorvastatin Calcium | 14 | $99 |
| Lisinopril | 11 | $72 |
Paid to pharmacies, not to this prescriber.
Other family in Keller
- David WeirDallas$959K
- Robin BeachHouston$428K
- April LopezMcAllen$417K
- Sarah AguilarHouston$199K
- Sie ThomasDallas$197K
- Anna CastroSan Antonio$184K
- Jill CampbellShenandoah$182K
- Angela AchaPflugerville$174K
- Susan BowlinIrving$164K
- Stephanie RodriguezCorpus Christi$159K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.